ASCO 2026 Highlights: RASolute 302, BREAKWATER and HERIZON-GEA-01 — The GI Cancer Studies That Defined ASCO 2026
MBBS MClinT(R) FRACP Sr Research Fellow and Clinical Lead
This educational activity is sponsored by BeOne Medicines. The views and opinions expressed by the presenters are their own and do not necessarily reflect those of BeOne. |
This program - FROM EVIDENCE TO PRACTICE is bought to you by med.ed.ai, Australia's first AI powered continuing medical education provider |